Title: Development and dosimetry of Pb-203 / Pb-212 labeled PSMA ligands – Bringing “the Lead” into PSMA-Targeting Alpha Therapy?
Authors: KRATOCHWIL CLEMENSDOS SANTOS JOSE CARLOSLEHNERT WENCKEBRUCHERTSEIFER FRANKMORGENSTERN ALFREDHABERKORN UWEKOPKA KLAUSMIER WALTER
Citation: NUKLEARMEDIZIN-NUCLEAR MEDICINE vol. 58 no. 2 p. 146
Publisher: SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
Publication Year: 2019
JRC N°: JRC113789
ISSN: 0029-5566 (online)
URI: https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0039-1683594
http://publications.jrc.ec.europa.eu/repository/handle/JRC113789
DOI: 10.1055/s-0039-1683594
Type: Articles in periodicals and books
Abstract: The development of a prostate-specific membrane antigen (PSMA)-ligand for labeling with different radioisotopes of lead and the approximation of the dosimetry of a simulated Pb-212 based alpha-therapy by using its Pb-203 imaging analogue.
JRC Directorate:Nuclear Safety and Security

Files in This Item:
There are no files associated with this item.


Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.